In early clinical trials, patients on GLP-1 agonists have achieved weight loss of 1520%, compared to the 510% typically seen with previous medications. Holistic approach to GLP-1 drugs Beyond weight loss, GLP-1 agonists have demonstrated the ability to reduce major cardiovascular events, combat fatty liver disease and alleviate obesity-related complications such as knee pain, sleep apnea, and acid reflux
In addition, the pro-carcinogenic effects of liraglutide on two highly aggressive breast cancer cell lines, MDA-MB-231 and MDA-MB-468, were most pronounced after 2 to 3 years of continuous exposure [18]
Products marketed as personalized blends with added vitamins or other ingredients, without a clear clinical rationale, are often designed to tout those additions to sidestep regulations rather than to benefit the patient
In 2018, the country spent $13.7bn on GLP-1 drugs
Divide the peptide amount in the vial (mg) by the volume of BAC water added (mL) to get the concentration in mg/mL
Vial number: A sequential identifier so you can track which vial you are using
